Skip to content

Clinical trials

Phase 1 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 1 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20084
20141
20152
20165
20192
20204
20223
20243
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Unknown status3
Withdrawn3
Not yet recruiting3
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong Suncadia Medicine Co., Ltd.3
Losordo, Douglas, M.D.2
M.D. Anderson Cancer Center2
University of Michigan2
Yale University2
Abramson Cancer Center at Penn Medicine1
Adjuvia Therapeutics, Inc.1
Astellas Gene Therapies1
Berlin Cures GmbH1
Capricor Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies31
Heart Failure15
Cardiovascular Diseases6
Friedreich Ataxia3
Heart Diseases3
Amyloidosis2
Breast Neoplasms2
Cardiomyopathy, Dilated2
Cardiomyopathy, Hypertrophic2
Hypertrophy2

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.